MAPT and Alzheimer disease: The prevailing hypothesis of Alzheimer's disease (AD) is that pathogenic amyloid beta (Aβ) acts as an initiating factor triggering the accumulation of downstream neuropathologies, including tau, and consequent neurodegeneration and dementia.1, 2, 3